Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine

OBJECTIVE: We determined if early improvement in painful physical symptoms (PPS) can be a predictor of remission in the treatment of major depressive disorder (MDD). METHODS: We included randomized, double-blind, parallel-group clinical trials of duloxetine (40–60 mg/day) versus placebo for the acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuoka, Hirofumi, Nishihara, Makoto, Fujikoshi, Shinji, Yoshikawa, Aki, Kuga, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626379/
https://www.ncbi.nlm.nih.gov/pubmed/29026309
http://dx.doi.org/10.2147/NDT.S143093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626379/
https://www.ncbi.nlm.nih.gov/pubmed/29026309
http://dx.doi.org/10.2147/NDT.S143093

Ejemplares similares